​“The pharmaceutical industry already works closely with the NHS to deliver the modern medicines patients need and to help relieve the burden of ill health in Scotland, said Jim Eadie, Director of ABPI Scotland.

“It is hoped that the new Unified NHS boards will promote health improvement and prevention and allow wider access to modern treatments, based on clear clinical evidence. We also support the concept of patients having more information about their condition and their treatment and welcome the Patient Information Initiative.”

The White Paper’s emphasis on improving clinical quality is also welcomed and the pharmaceutical industry looks forward to working with the Scottish Executive in the development of the new research strategy recognising the evidence base for new medicines is of the highest standard.

For further information, please contact: ABPI Press Office 020 7747 1410